1. Home
  2. NBIX vs GEN Comparison

NBIX vs GEN Comparison

Compare NBIX & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$166.05

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Logo Gen Digital Inc.

GEN

Gen Digital Inc.

HOLD

Current Price

$30.89

Market Cap

14.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
GEN
Founded
1992
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
14.9B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
NBIX
GEN
Price
$166.05
$30.89
Analyst Decision
Strong Buy
Buy
Analyst Count
29
11
Target Price
★ $207.50
$32.28
AVG Volume (30 Days)
1.3M
★ 7.4M
Earning Date
11-02-2026
10-28-2026
Dividend Yield
N/A
★ 1.68%
EPS Growth
41.95
★ 52.43
EPS
★ 5.26
0.83
Revenue
$161,626,000.00
★ $6,676,000,000.00
Revenue This Year
$36.46
$9.28
Revenue Next Year
$17.43
$6.78
P/E Ratio
★ $31.49
$35.90
Revenue Growth
★ 977.51
N/A
52 Week Low
$122.14
$17.78
52 Week High
$186.12
$31.65

Technical Indicators

Market Signals
Indicator
NBIX
GEN
Relative Strength Index (RSI) 76.47 72.01
Support Level $152.67 $29.55
Resistance Level $169.57 $29.87
Average True Range (ATR) 3.61 0.89
MACD 2.23 0.83
Stochastic Oscillator 86.44 86.31

Price Performance

Historical Comparison
NBIX
GEN

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About GEN Gen Digital Inc.

Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.

Share on Social Networks: